Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 8610304)

Published in Stroke on March 01, 1996

Authors

S E Starkstein1, L Sabe, S Vazquez, A Teson, G Petracca, E Chemerinski, G Di Lorenzo, R Leiguarda

Author Affiliations

1: Department of Behavioral Neurology, Raul Carrea Institute of Neurological Research, Buenos Aires, Argentina.

Articles citing this

Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry (2004) 2.32

Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol (2000) 1.64

Brief cognitive assessment for patients with cerebral small vessel disease. J Neurol Neurosurg Psychiatry (2005) 1.47

White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 1.16

Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol (2000) 1.14

Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology (2005) 1.14

Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow. Neuropsychologia (2000) 1.12

Decreased physical activity predicts cognitive dysfunction and reduced cerebral blood flow in heart failure. J Neurol Sci (2014) 0.84

Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms. Front Endocrinol (Lausanne) (2014) 0.83

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. Int J Alzheimers Dis (2011) 0.81

Metacognition in the behavioral variant of frontotemporal dementia and Alzheimer's disease. Neuropsychology (2014) 0.80

Differentiating Alzheimer's disease from subcortical vascular dementia with the FAB test. J Neurol (2006) 0.79

Articles by these authors

Retracted Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med (1998) 4.93

Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg (1990) 3.41

Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci (1992) 3.21

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry (2000) 2.12

Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry (1995) 1.97

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 1.93

Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol (1999) 1.81

Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology (2005) 1.74

A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease. Arch Neurol (1995) 1.60

Sleep benefit in Parkinson's disease. Mov Disord (1997) 1.56

Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Am J Med (1999) 1.55

Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54

Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol (1998) 1.53

Bovine seminal ribonuclease: structure at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr (1993) 1.53

Periodic limb movements in syringomyelia and syringobulbia. Mov Disord (2000) 1.51

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy (2002) 1.51

Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry (2001) 1.51

Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology (1998) 1.49

Superficial cerebral astrocytoma attached to dura. Report of six cases in infants. Cancer (1984) 1.47

Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators. J Hepatol (2000) 1.47

Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci (Lond) (1998) 1.47

Retracted Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. AIDS (2000) 1.45

Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry (2001) 1.43

Respiratory disturbances during sleep in syringomyelia and syringobulbia. Neurology (1999) 1.40

[Spinal arachnoiditis as a complication of peridural anesthesia]. Medicina (B Aires) (1993) 1.40

Apathy following cerebrovascular lesions. Stroke (1993) 1.40

Asymbolia for pain: a sensory-limbic disconnection syndrome. Ann Neurol (1988) 1.40

Differential recovery of languages in a bilingual patient: a case study using selective amytal test. Brain Lang (1990) 1.39

Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible? World J Urol (2003) 1.39

Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis (1998) 1.38

Anosognosia in Alzheimer's disease: a study of associated factors. J Neuropsychiatry Clin Neurosci (1995) 1.37

Brain damage in National Hunt jockeys. Lancet (1976) 1.33

Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses (1998) 1.29

Is there a specific visuo-spatial impairment in Parkinsonians? J Neurol Neurosurg Psychiatry (1986) 1.28

Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord (1998) 1.15

Emerging pathologies in aquaculture: effects on production and food safety. Vet Res Commun (2003) 1.13

Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia (2005) 1.11

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res (2001) 1.11

Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br J Psychiatry (1997) 1.09

Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry (1996) 1.07

Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry (1994) 1.06

Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol (1990) 1.05

Neuropsychological disturbances in hemiparkinson's disease. Neurology (1987) 1.05

Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. Eur J Surg Oncol (2008) 1.05

Decision-making in Parkinson's disease patients with and without pathological gambling. Eur J Neurol (2009) 1.03

Neuropsychological correlates of apathy and depression in patients with dementia. Neurology (1999) 1.03

Dengue haemorrhagic fever in Cuba. II. Clinical investigations. Trans R Soc Trop Med Hyg (1984) 1.02

Immunopathology of leishmaniasis: an update. Int J Immunopathol Pharmacol (2007) 1.01

Cognitive functions in major depression and Parkinson disease. Arch Neurol (1997) 1.01

Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.00

Growth rate of secondary hydatid cysts of the brain. Case report. J Neurosurg (1985) 1.00

Anosognosia in patients with cerebrovascular lesions. A study of causative factors. Stroke (1992) 1.00

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy (2001) 1.00

Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol (1999) 0.98

A SPECT study of delusions in Alzheimer's disease. Neurology (1994) 0.97

Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians. Mech Ageing Dev (1997) 0.97

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr (2001) 0.97

Behavioral effects of damage to the right insula and surrounding regions. Cortex (1987) 0.96

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol (2009) 0.95

Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease. Psychol Med (1995) 0.95

Two domains of anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 0.94

Prevalence and clinical correlates of pathological affective display in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1995) 0.94

Emotion processing in the minimally conscious state. J Neurol Neurosurg Psychiatry (2004) 0.93

Addenbrooke's Cognitive Examination validation in Parkinson's disease. Eur J Neurol (2008) 0.93

Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol (1996) 0.92

Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study. Clin Neuropharmacol (1999) 0.92

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci (1996) 0.91

The specificity of depressive symptoms in patients with Alzheimer's disease. Am J Psychiatry (2001) 0.91

Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damage. J Neurol Neurosurg Psychiatry (1999) 0.90

Abnormal visual habituation in pediatric photosensitive epilepsy. Clin Neurophysiol (2010) 0.90

gamma-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity (1993) 0.89

Enhancing a declarative memory in humans: the effect of clonazepam on reconsolidation. Neuropharmacology (2012) 0.89

Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study. Eur J Neurol (2013) 0.89

Developmental cortical anomalies in Asperger's syndrome: neuroradiological findings in two patients. J Neuropsychiatry Clin Neurosci (1990) 0.88

Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. Chest (1996) 0.88

The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease. Eur J Neurol (1995) 0.88